Parkinson Disease, Familial, Type 1
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
46
|
27
|
0.090 |
None |
1.000 |
9 |
3
|
2015 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2020 |
Pick Disease of the Brain
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
213
|
83
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
320
|
215
|
0.030 |
None |
1.000 |
3 |
2
|
2018 |
2019 |
Sporadic Parkinson disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
179
|
65
|
0.030 |
None |
1.000 |
3 |
2
|
2015 |
2017 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Essential Tremor
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
122
|
79
|
0.020 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
None |
1.000 |
2 |
3
|
2015 |
2015 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Serine measurement
|
phenotype |
|
Laboratory Procedure
|
9
|
18
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
816
|
176
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Amino acids measurement
|
group |
|
Laboratory Procedure
|
53
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cardiomyopathy, Familial Idiopathic
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
773
|
243
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Invasive Ductal Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
414
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lupus Vasculitis, Central Nervous System
|
disease |
Infections; Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lafora Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
92
|
32
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Mitochondrial Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
284
|
84
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |